• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
man juggling in the street
Pharma

ImmunityBio shares tank despite ph. 3 win in first-line NMIBC

With a phase 3 win in front-line non-muscle invasive bladder cancer, ImmunityBio is heading to the FDA for a label expansion.
Donavyn Coffey Nov 10, 2026 3:06pm
Asking More of Science How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Asking More of Science: How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Brought to you by Daiichi Sankyo, Inc.
Summit

Summit sheds commercial leaders before ivonescimab FDA decision

Nov 10, 2026 2:12pm
JNJ

J&J's Caplyta scores 2nd ph. 3 win in bipolar mania

Nov 10, 2026 10:01am
Business person contemplating how to navigate a maze made of money
Favicon Fierce Biotech

Why experts fear fallout from Treasury’s China biotech crackdown

Nov 10, 2026 9:30am
WuXi

WuXi AppTec removed from US list of Chinese military companies

Nov 10, 2026 8:51am
More News

FDA orders GLP-1s add eye risk to labels

Nov 10, 2026 8:31am

AchieveRx stubs out old identity for smoking cessation launch

Nov 10, 2026 8:04am

Insulet’s Marvel collab returns with new diabetes superhero

Nov 10, 2026 7:00am

Vertex layoffs hit 78 Crinetics employees following $10B deal

Nov 10, 2026 3:00am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings